Winstrol 100mg/ml Stanozolol base Oil Steroids Injectable

Description

Winstrol Stanozolol Oral Androgen Research Peptide

How It Works

The pharmacology of Stanozolol Winstrol Oil is characterized by its high affinity for the androgen receptor and its unique interaction with the progesterone receptor. Stanozolol binds to microsomal androgen receptors (mAR) within skeletal muscle tissue, facilitating rapid non-genomic signaling cascades. The pyrazole-modified molecule inhibits SHBG synthesis in hepatic cells, thereby increasing the circulating fraction of free, bioavailable testosterone and other exogenous ligands. Androgen receptor activation triggers RNA polymerase activity, which accelerates the synthesis of contractile proteins and enhances nitrogen retention. Binding kinetics indicate a high affinity for the AR with a Ki value of approximately 0.5 to 1.5 nM. Quantitatively, the oil-based delivery system provides a terminal half-life of roughly 24 hours (±4 hours), offering a smoother pharmacokinetic profile than traditional oral titration. Unlike Anavar Oxandrolone, stanozolol exhibits a profound ability to lower Sex Hormone-Binding Globulin (SHBG) levels, making it a critical tool for studying hormonal synergy.

Compound Background

Stanozolol, widely identified by the research moniker Winstrol, is a synthetic 17β-hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole, functioning as a high-potency androgen receptor agonist within a lipid-based parenteral delivery system. Stanozolol binds to the nuclear androgen receptor to initiate genomic transcription pathways associated with myogenic differentiation and protein accrual. This formulation is structurally distinct from other DHT derivatives due to the fusion of a pyrazole ring at the 3,2-position of the A-ring, which significantly enhances its anabolic potency. Researchers prioritize this oil-based variant to investigate metabolic signaling and tissue remodeling in advanced biological models while avoiding the localized inflammatory response frequently observed with aqueous suspensions.

Specification Sheet

• CAS Number: 10418-03-8
• Molecular Formula: C21H32N2O
• Molecular Weight: 328.49 g/mol
• Appearance: Clear to pale straw viscous solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Solubility: Optimized in organic carrier lipids like Miglyol 840 or Ethyl Oleate

Research Observations

• Myofibrillar Hypertrophy: Investigators observe significant increases in muscular hardness and density without the interference of subcutaneous water retention.
• SHBG Modulation: Based on community feedback, effects include a marked increase in the efficiency of other co-administered androgens due to reduced protein binding.
• Enhanced Vascularity: Experimental findings suggest a noticeable increase in peripheral vascularity and ‘dryness’ in low-body-fat research models.
• Positive Nitrogen Flux: Observed effects include sustained protein synthesis and amino acid sparing during phases of caloric restriction or metabolic stress.
• Neurological Drive: Research models indicate a dose-dependent increase in neuromuscular force production and central nervous system (CNS) output.

Key Points:
Stanozolol Winstrol Oil remains a foundational research tool for inducing non-aromatizing anabolic shifts and studying the systemic regulation of Sex Hormone-Binding Globulin.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.